A consortium including Elliott Investment Management L.P. is in advanced talks to acquire Syneos Health, Inc. (NasdaqGS:SYNH), according to people familiar with the matter. The investor group, which also includes former KKR & Co. Inc. (NYSE:KKR) dealmaker Jim Momtazee's Patient Square Capital, LP and Veritas Capital Fund Management, L.L.C, could announce a deal for the drug-research services company as soon as this week, the people said.
1st Jan change | Capi. | |
---|---|---|
+37.26% | 51.07B | |
-8.07% | 38.78B | |
+34.72% | 38.61B | |
-8.98% | 27.32B | |
+11.86% | 26.35B | |
-19.40% | 19.46B | |
+40.05% | 13.58B | |
+29.74% | 12.46B | |
-3.91% | 11.75B |